A 2019 TOP DOC
An internationally recognized foot and ankle surgeon, Dr. Lew Schon is Director of Orthopedic Innovation at The Institute for Foot and Ankle Reconstruction at Mercy.
Mercy doctors offer a breakthrough treatment for hepatitis C that cures most patients and saves lives. Hepatitis C is an infection of the liver caused by the hepatitis C virus and can lead to permanent liver damage if untreated.
Dr. David Riseberg, Chief of Medical Oncology and Hematology at Mercy, leads a team of Board Certified physicians who provide compassionate care and comprehensive treatment plans.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
At The Center for Liver and Hepatobiliary Diseases at Mercy, Dr. Paul Thuluvath, Dr. Anurag Maheshwari and Dr. Hwan Yoo offer some of the best treatment options available for liver diseases. Specializing in liver cancer diagnosis and treatment, Mercy's doctors offer transarterial chemoembolization as a treatment for liver cancer.
Transarterial chemoembolization is a minimally invasive procedure that allows for chemotherapy to be administered directly into a liver tumor while blocking the tumor’s blood supply.
During a transarterial chemoembolization, a catheter is inserted into an incision in the groin area. The catheter is guided through blood vessels to the liver. Through the catheter, the chemotherapy is targeted directly to the liver tumor. The embolization materials also are inserted through the catheter and are used to block the blood supply. This blocking of the blood supply during transarterial chemoembolization enables the chemotherapy to stay in the liver rather than be carried through the blood stream.
Transarterial chemoembolization is a treatment option for liver cancer.
The Institute for Digestive Health & Liver Disease at Mercy Medical Center brings Baltimore-based top gastroenterologists, doctors, surgeons and specialists to the patient communities of the Mid-Atlantic region with leading treatments for diseases and conditions affecting the digestive tract, including liver and hepatobiliary diseases, inflammatory bowel and colorectal diseases such as Crohn's disease or colitis, conditions of the pancreas, heartburn and reflux disease (GERD), and stomach and intestinal disorders.
A 2019 TOP DOC
Dr. Mary Harris is a regionally recognized gastroenterologist and Medical Director of Mercy's Center for Inflammatory Bowel and Colorectal Diseases.
Learn more about a long-term health struggle and the trusting relationship one patient established with her doctor at The Institute for Digestive Health and Liver Disease.